Drug Type Small molecule drug |
Synonyms Ca-DTPA, Calcium Trisodium Pentetate, Calcium trisodium pentetate (INN) + [5] |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (11 Aug 2004), |
Regulation- |
Molecular FormulaC14H18CaN3Na3O10 |
InChIKeyAYFCVLSUPGCQKD-UHFFFAOYSA-I |
CAS Registry12111-24-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D05419 | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Poisoning | JP | 01 Jul 2011 | |
Metal Metabolism, Inborn Errors | US | 11 Aug 2004 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Streptococcal Infections | Phase 3 | JP | 08 Dec 2009 |
Phase 1/2 | 1 | shgzflzyqp(kitzcnmwsy) = ghqikgqwse xgetdmovaw (lljuppihyy, mfneziahrj - ctttnbgusd) View more | - | 06 Apr 2018 |